This Key Event Relationship is licensed under the Creative Commons BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.
Relationship: 2025
Title
STAT5 inhibition leads to Suppression of STAT5 binding to cytokine gene promoters
Upstream event
Downstream event
AOPs Referencing Relationship
| AOP Name | Adjacency | Weight of Evidence | Quantitative Understanding | Point of Contact | Author Status | OECD Status |
|---|---|---|---|---|---|---|
| Inhibition of JAK3 leading to impairment of T-Cell Dependent Antibody Response | adjacent | High | High | Brendan Ferreri-Hanberry (send email) | Under development: Not open for comment. Do not cite | Under Development |
Taxonomic Applicability
Sex Applicability
| Sex | Evidence |
|---|---|
| Mixed | High |
Life Stage Applicability
| Term | Evidence |
|---|---|
| All life stages | High |
STAT proteins bind with their SH2 domains (which are located between amino acids 600 and 700) to phosphorylated tyrosine residues of transmembrane receptors (Heim, et al. 1995, Stahl, et al. 1995). Once STATs are bound to the receptors, the receptor-associated Jak kinases phosphorylate them on a single tyrosine residue located carboxy terminal of the SH2 domain. Changing this tyrosine to phenylalanine results in STATs that are no longer functional (Shuai, et al. 1993). Two STATs dimerize through specific reciprocal SH2–phosphotyrosine interaction and translocate to the nucleus. After translocation into the nucleus, STATs bind DNA response elements in promoters of target genes. The putative DNA-binding domain lies between amino acids 400 and 500. After DNA binding STATs interact directly or indirectly with the RNA polymerase II complex. The DNA sequence elements in the promoters of genes that bind STAT proteins can be classified in two groups. The prototype of the first class is the interferon-stimulated response element (ISRE).
The second class comprises the GAS-like response elements. STAT5 homodimers have been shown to bind to at least one of the GAS-like elements (Heim 1996).
| ID | Experimental Design | Species | Upstream Observation | Downstream Observation | Citation (first author, year) | Notes |
|---|
| Title | First Author | Biological Plausibility |
Dose Concordance |
Temporal Concordance |
Incidence Concordance |
|---|
Biological Plausibility
Dose Concordance Evidence
Temporal Concordance Evidence
Incidence Concordance Evidence
Uncertainties and Inconsistencies
As a property of STAT, it is known that DNA binding ability is acquired by forming a dimer, and it is considered that a modifying factor does not intervene in that respect.
CD2 signaling of human PBMCs results in activation of the -3.6-kb IFN-γ promoter. In contrast, mutation of the -3.6-kb STAT5 site attenuates promoter activity. Functional activation is accompanied by STAT5A, but scant STAT5B nucleoprotein binds to the STAT5 binding site on the IFN-γ promoter, as determined by competition and supershift assays. Western and fluorescence-activated cell sorting analyses revealed increased phospho-STAT5 following CD2 signaling (Gonsky, et al. 2004).
Response-response Relationship
Inhibition of phosphatase activity by calyculin A treatment of YT cells resulted in a significant induction of serine phosphorylation of JAK3 and STAT5, and serine/threonine phosphorylation of IL-2Rβ. Moreover, inhibition of protein phosphatase 2 (PP2A) diminished IL-2-induced tyrosine phosphorylation of IL-2Rβ, JAK3, and STAT5, and abolished STAT5 DNA binding activity (Ross, et al. 2010).
Time-scale
Known Feedforward/Feedback loops influencing this KER
IL-2 acts on the same cell that secretes the cytokine. For instance, IL-2 produced by T cells operates on the same T cells that produce this cytokine, or on neighboring cells. With the highest levels in secondary lymphoid organs, IL-2 is believed to act in an autocrine or paracrine manner to support effector and memory CD8 T cell differentiation (Kalia and Sarkar 2018).